DataHow Secures Bridge Financing to Accelerate AI-Driven Bioprocess Platform
Swiss AI‑powered bioprocess platform DataHow closed a bridge‑financing round that extends its Series A, positioning ...
Read story →Tag: Biopharma
View all →
Tempus AI to Acquire Personalis in $16.25-Per-Share Deal to Expand MRD Testing and Biopharma Data Capabilities
Tempus AI Inc. (NASDAQ: TEM) announced it will purchase all outstanding shares of Personalis Inc. (PSNL) that it does no...
Read story →
Syndax Pharmaceuticals Holds 2026 Annual Shareholder Meeting Amid Strong Oncology Pipeline and Recent Financial Growth
On June 10, 2026, Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) convened its annual meeting of stockholders through a recor...
Read story →